SCHEMBL6933334

SCHEMBL6933334

COc1ccc(-c2cc3ccccc3[nH]2)cc1NC(=S)NCCNC(=O)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.45
SMO Q99835 1/20 0.44
MAPT P10636 7/20 0.40
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
ALOX12 P18054 5/20 0.40
LMNA P02545 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
HTT P42858 1/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494027 0.91 ALOX15 (0.48) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6933336 0.85 ALOX15 (0.43) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6495090 0.79 MEN1 (0.38) ALOX15MAPTMEN1KMT2AALOX12
SCHEMBL6494033 0.76 ALOX15 (0.46) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6495159 0.75 RAB9A (0.51) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6494681 0.75 SMO (0.54) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6505453 0.74 SMO (0.50) ALOX15SMOMAPTLMNAGAA
SCHEMBL6496744 0.73 KMT2A (0.51) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6504271 0.73 SMO (0.55) ALOX15SMOMAPTMEN1KMT2A
SCHEMBL6504212 0.72 ALDH1A1 (0.48) ALOX15SMOMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors CONNOR DAVID THOMAS (US) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038943-A1 Indole and benzimidazole 15-lipoxygenase inhibitors ALOX15, ALOX5, ALOX12 ALOX15 1/4885SMO 2783/4885MAPT 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.